STOCK TITAN

Incyte Genomics Inc (INCY) Revenue by Year

INCY

Incyte Genomics Inc generated $5.1B in revenue in fiscal year 2025. This represents an increase of 21.2% from the prior fiscal year. Over the trailing 12 months, Q2 FY2025 through Q1 FY2026, the same line adds up to $5.4B in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Incyte Genomics Inc has filed alongside them.

FY2025 annual
Revenue $5.1B
YoY +21.2%
5Y CAGR +14.0%
10Y CAGR +21.2%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

INCY Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Revenue$5.4B$5.1B+21.2%$4.2B+14.8%$3.7B+8.9%$3.4B+13.7%$3.0B+12.0%$2.7B+23.5%$2.2B+14.7%$1.9B+22.5%$1.5B+38.9%$1.1B+46.7%$753.8M+47.4%$511.5M+44.1%$354.9M+19.5%$297.1M+214.5%$94.5M

TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

INCY Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Revenue$1.3B+20.9%$1.5B+27.8%$1.4B+20.0%$1.2B+16.5%$1.1B+19.5%$1.2B+16.3%$1.1B+23.8%$1.0B+9.3%$880.9M+8.9%$1.0B+9.3%$919.0M+11.6%$954.6M+4.7%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Incyte Genomics Inc financials

Frequently Asked Questions

What was Incyte Genomics Inc's revenue in fiscal year 2025?

Incyte Genomics Inc generated $5.1B in revenue in fiscal year 2025.

How fast is Incyte Genomics Inc's revenue growing?

Incyte Genomics Inc (INCY) revenue rose by 21.2% year over year, from $4.2B to $5.1B in fiscal year 2025.

What is Incyte Genomics Inc's revenue over the last twelve months?

Incyte Genomics Inc (INCY) reported $5.4B in revenue over the trailing 12 months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Incyte Genomics Inc (INCY) revenue went from $94.5M in fiscal year 2011 to $5.1B in fiscal year 2025.

Incyte Genomics Inc (INCY) reported $1.3B in revenue in Q1 2026. This represents an increase of 20.9% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Incyte Genomics Inc (INCY) reported on that line in every period on record.